Moody Aldrich Partners’s Boston Scientific BSX Stock Holding History

Moody Aldrich Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,210	Closed	-$216K	–	189
2025 Q3	$216K	Hold	2,210	–	–	0.04%	180
2025 Q2	$237K	Sell	2,210 -694	-24%	-$70.2K	0.05%	163
2025 Q1	$293K	Sell	2,904 -443	-13%	-$44.6K	0.06%	141
2024 Q4	$299K	Buy	3,347 +163	+5%	+$14.3K	0.06%	165
2024 Q3	$267K	Sell	3,184 -550	-15%	-$43.4K	0.05%	172
2024 Q2	$288K	Sell	3,734 -3,533	-49%	-$259K	0.06%	171
2024 Q1	$498K	Sell	7,267 -18	-0.2%	-$1.16K	0.08%	140
2023 Q4	$421K	Sell	7,285 -516	-7%	-$27.5K	0.08%	145
2023 Q3	$411K	Buy	+7,801	New	+$409K	0.08%	137

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Moody Aldrich Partners's BSX Position: Q4 2025 in Review

Moody Aldrich Partners sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,210 shares — an estimated $216K sold.

Moody Aldrich Partners first reported a position in BSX in Q3 2023 and held it in 9 quarters. The position peaked at $498K in Q1 2024. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Moody Aldrich Partners reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Moody Aldrich Partners sold 2,210 Boston Scientific shares in Q4 2025, an estimated $216K.
Moody Aldrich Partners first reported a position in Boston Scientific in Q3 2023 and held it in 9 quarters.
Moody Aldrich Partners's Boston Scientific position peaked at $498K in Q1 2024.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Moody Aldrich Partners's 13F filing for Q4 2025, filed 30 Jan 2026.